Tony Elliott

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.

Thierry Gil, Camilla Thellenberg Karlsson, I. Tannock, 2013, The Lancet. Oncology.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

Wei Yuan, Nina Tunariu, Rosalind Eeles, 2015, The New England journal of medicine.

Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect.

Lucy E Kershaw, R. Cowan, L. Kershaw, 2013, European journal of radiology.